TRACON Pharmaceuticals (TCON) News Today $0.05 +0.02 (+66.67%) (As of 10:27 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period TRACON Pharmaceuticals (NASDAQ:TCON) Now Covered by Analysts at StockNews.comNovember 13, 2024 | americanbankingnews.comTRACON Pharma (OTC:TCON) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comTRACON Pharmaceuticals Announces it Will Wind Down OperationsJuly 30, 2024 | globenewswire.comTRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage Repair Inhibitor, in Recurrent Glioblastoma PatientsJune 11, 2024 | globenewswire.comTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q1 2024 Earnings Call TranscriptMay 15, 2024 | msn.comQ1 2024 TRACON Pharmaceuticals Inc Earnings CallMay 15, 2024 | finance.yahoo.comTRACON Pharmaceuticals Inc (TCON) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 15, 2024 | finance.yahoo.comTCON Stock Earnings: TRACON Pharma Misses EPS for Q1 2024May 14, 2024 | investorplace.comTRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 14, 2024 | finance.yahoo.comTRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 14, 2024 | globenewswire.comTRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024May 7, 2024 | globenewswire.comTRACON Pharmaceuticals IncApril 26, 2024 | money.usnews.comTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Sees Significant Drop in Short InterestTRACON Pharmaceuticals, Inc. (NASDAQ:TCON - Get Free Report) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 744,900 shares, a drop of 60.8% from the March 15th total of 1,900,000 shares. Based on an average daily volume of 3,400,000 shares, the short-interest ratio is presently 0.2 days.April 11, 2024 | marketbeat.comBuy Rating Reaffirmed for TRACON Pharmaceuticals Post-Reverse Split and Envafolimab Valuation UpdateApril 10, 2024 | markets.businessinsider.comTRACON announces 1-for-20 reverse stock splitApril 10, 2024 | uk.investing.comWall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024April 10, 2024 | investorplace.comTrading was temporarily halted for "TCON" at 07:04 PM with a stated reason of "News pending."April 10, 2024 | marketbeat.comShares of Tracon Pharmaceuticals Tumble 22% on Reverse SplitApril 8, 2024 | marketwatch.comTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Reverse Stock SplitApril 8, 2024 | finanznachrichten.deTRACON Pharmaceuticals Announces Reverse Stock SplitApril 8, 2024 | globenewswire.comBuy Rating Affirmed for TRACON Pharmaceuticals Amid Promising Envafolimab Trial OutlookApril 4, 2024 | markets.businessinsider.comTracon Pharma drops after pivotal data for cancer drugApril 3, 2024 | msn.comTRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as PlannedApril 3, 2024 | finance.yahoo.comJonesTrading Reaffirms Their Hold Rating on TRACON Pharmaceuticals (TCON)March 13, 2024 | markets.businessinsider.comBuy Rating for TRACON Pharmaceuticals on Strong Financials and Promising Clinical TrialsMarch 8, 2024 | markets.businessinsider.comTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate UpdateMarch 7, 2024 | finanznachrichten.deTRACON Pharmaceuticals, Inc. (TCON) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | seekingalpha.comTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | finance.yahoo.comTRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate UpdateMarch 5, 2024 | globenewswire.comTracon Q4 2023 Earnings PreviewMarch 4, 2024 | msn.comA Preview Of TRACON Pharma's EarningsMarch 4, 2024 | benzinga.comTRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024February 28, 2024 | globenewswire.comTRACON Pharmaceuticals, Inc. (TCON)February 13, 2024 | finance.yahoo.comTRACON Pharma Stock (NASDAQ:TCON), Guidance and ForecastDecember 23, 2023 | benzinga.comBuy Rating for TRACON Pharmaceuticals on Envafolimab’s Promising Trial Outcomes and Strong Market PotentialDecember 21, 2023 | markets.businessinsider.comTCON TRACON Pharmaceuticals, Inc.November 25, 2023 | seekingalpha.comWhy Is Tracon Pharmaceuticals (TCON) Stock Up 19% Today?November 21, 2023 | msn.comAnalysts Offer Insights on Healthcare Companies: TRACON Pharmaceuticals (TCON), Anavex Life Sciences (AVXL) and Genmab (GMAB)November 21, 2023 | markets.businessinsider.comTRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront PaymentNovember 20, 2023 | finance.yahoo.comPromising Financial and Clinical Prospects Bolster Buy Rating for TRACON PharmaceuticalsNovember 15, 2023 | markets.businessinsider.comTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q3 2023 Earnings Call TranscriptNovember 12, 2023 | finance.yahoo.comTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 10, 2023 | finanznachrichten.deTRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 9, 2023 | finance.yahoo.comTRACON Pharmaceuticals (TCON) Price Target Increased by 21.88% to 6.63November 1, 2023 | msn.comTRACON Pharmaceuticals Inc TCONNovember 1, 2023 | morningstar.comTRACON to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 9, 2023October 31, 2023 | finance.yahoo.comWhy Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving PremarketOctober 27, 2023 | benzinga.comTRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as PlannedSeptember 18, 2023 | finance.yahoo.com7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot PoleSeptember 2, 2023 | finance.yahoo.comJonesTrading Downgrades TRACON Pharmaceuticals (TCON)August 22, 2023 | msn.com Get TRACON Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TCON and its competitors with MarketBeat's FREE daily newsletter. Email Address My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report... The Next SpaceX Pre-IPO TCON Media Mentions By Week TCON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TCON News Sentiment▼0.000.47▲Average Medical News Sentiment TCON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TCON Articles This Week▼00▲TCON Articles Average Week Get TRACON Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TCON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biodexa Pharmaceuticals News Today Peak Bio News Today Elevai Labs News Today TC Biopharm News Today NexImmune News Today Seelos Therapeutics News Today Navidea Biopharmaceuticals News Today Smart for Life News Today Vaxxinity News Today Ampio Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TCON) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRACON Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRACON Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
